Refractory Chronic Lymphocytic Leukemia with Central Nervous System Involvement: A Case Report with Literature Review

References

• Chihara D, Ito H, Matsuda T, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164(4):536–545. doi:10.1111/bjh.1265924245986
   PubMed Web of Science ®Google Scholar
• Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019;94(11):1266–1287. doi:10.1002/ajh.2559531364186
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S, Zenz T. Understanding and managing ultra high-risk chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:481–488. doi:10.1182/asheducation-2010.1.48121239840
   PubMed Web of Science ®Google Scholar
• Hanse MC, Van’t Veer MB, van Lom K, et al. Incidence of central nervous system involvement in chronic lymphocytic leukemia and outcome to treatment. J Neurol. 2008;255(6):828–830. doi:10.1007/s00415-008-0710-418446313
   PubMed Web of Science ®Google Scholar
• Lopes da Silva R. Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2012;12(3):164–179. doi:10.1016/j.clml.2011.10.00522192500
   PubMed Web of Science ®Google Scholar
• Bernard S, Goldwirt L, Amorim S, et al. Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood. 2015;126(14):1695–1698. doi:10.1182/blood-2015-05-64783426239089
   PubMed Web of Science ®Google Scholar
• Wanquet A, Birsen R, Bonnet C, et al. Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients. Br J Haematol. 2017;176(1):37–49. doi:10.1111/bjh.1438727858991
   PubMed Web of Science ®Google Scholar
• Moazzam AA, Drappatz J, Kim RY, et al. Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review. J Neurooncol. 2012;106(1):185–200. doi:10.1007/s11060-011-0636-z21769650
   PubMed Web of Science ®Google Scholar
• Molica S. A systematic review on Richter syndrome: what is the published evidence? Leuk Lymphoma. 2010;51(3):415–421. doi:10.3109/1042819090351519220078326
   PubMed Web of Science ®Google Scholar
• Cramer SC, Glaspy JA, Efird JT, et al. Chronic lymphocytic leukemia and the central nervous system: a clinical and pathological study. Neurology. 1996;46(1):19–25. doi:10.1212/WNL.46.1.198559372
   PubMed Web of Science ®Google Scholar
• Brick WG, Majmundar M, Hendricks LK, et al. Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia. Leuk Lymphoma. 2002;43(1):199–201. doi:10.1080/1042819021019111908730
   PubMed Web of Science ®Google Scholar
• Cabannes-Hamy A, Lemal R, Goldwirt L, et al. Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. Am J Hematol. 2016;91(3):E17–19. doi:10.1002/ajh.2427926689870
   PubMed Web of Science ®Google Scholar
• Tucker DL, Naylor G, Kruger A, et al. Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement - a multi-centre case series from the United Kingdom. Br J Haematol. 2017;178(2):327–329. doi:10.1111/bjh.1412227197509
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Dunleavy K, Roschewski M, et al. Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma. Cancer Cell. 2017;31(6):833–843.e835. doi:10.1016/j.ccell.2017.04.01228552327
   PubMed Web of Science ®Google Scholar
• Grommes C, Pastore A, Palaskas N, et al. Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma. Cancer Discov. 2017;7(9):1018–1029. doi:10.1158/2159-8290.CD-17-061328619981
   PubMed Web of Science ®Google Scholar
• Rizvi W, Truong Q. Unusual relapse of chronic lymphocytic leukemia after remission. Cureus. 2018;10(2):e2176.29651369
   PubMed Web of Science ®Google Scholar
• Beziat G, Gauthier M, Protin C, et al. Venetoclax with high-dose methotrexate and rituximab seem effective and well-tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: a case report. Clin Case Rep. 2020;8(2):269–273. doi:10.1002/ccr3.258032128171
   PubMed Web of Science ®Google Scholar
• Reda G, Cassin R, Dovrtelova G, et al. Venetoclax penetrates in cerebrospinal fluid and may be effective in chronic lymphocytic leukemia with central nervous system involvement. Haematologica. 2019;104(5):e222–e223. doi:10.3324/haematol.2018.21315730765472
   PubMed Web of Science ®Google Scholar
• Akdogan O, Guven T, Altindal S, et al. An uncommon neurological manifestation of chronic lymphocytic leukemia: longitudinally extensive transverse myelitis. Mult Scler Relat Disord. 2020;37:101455. doi:10.1016/j.msard.2019.10145531670207
   PubMed Web of Science ®Google Scholar
• Witton LA, Menon S, Perera KS. Central nervous system involvement with chronic lymphocytic leukemia. Can J Neurol Sci. 2019;46(5):640–641. doi:10.1017/cjn.2019.7531120004
   PubMed Web of Science ®Google Scholar
• Gallastegui N, Cassidy DP, Heros DO, et al. Central nervous system involvement by small lymphocytic lymphoma after a myxoma-related embolic event. Case Rep Hematol. 2019;2019:1825491.31827948
   PubMed Web of Science ®Google Scholar
• Guo R, Zhang X, Niu C, et al. Primary central nervous system small lymphocytic lymphoma in the bilateral ventricles: two case reports. BMC Neurol. 2019;19(1):200. doi:10.1186/s12883-019-1430-331426757
   PubMed Web of Science ®Google Scholar
• Otani R, Uzuka T, Matsuda H, et al. Brain invasion by chronic lymphocytic leukemia. Neuropathology. 2019;39(1):54–57. doi:10.1111/neup.1252530474266
   PubMed Web of Science ®Google Scholar
• Mousinho F, Mendes T, Sousa E, et al. Treatment sequencing in a chronic lymphocytic leukemia patient with central nervous system involvement. Case Rep Hematol. 2018;2018:7817918.29977629
   PubMed Web of Science ®Google Scholar
• Wąsik-Szczepanek E, Szymczyk A, Szczepanek D, et al. Richter syndrome: a rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma. Adv Clin Exp Med. 2018;27(12):1683–1689. doi:10.17219/acem/7590330156387
   PubMed Web of Science ®Google Scholar
• Christoforidou A, Kapsas G, Bezirgiannidou Z, et al. Successful treatment of chronic lymphocytic leukemia multifocal central nervous system involvement with ibrutinib. Turk J Haematol. 2018;35(2):147–149. doi:10.4274/tjh.2017.031329391330
   PubMed Web of Science ®Google Scholar
• Timmers NKLM, de Maar JS, van Kruijsdijk RCM, et al. Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature. Ann Hematol. 2018;97(9):1627–1632. doi:10.1007/s00277-018-3329-229707738
   PubMed Web of Science ®Google Scholar
• Xu L, Song JC, Sun XH, et al. Richter’s syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: a case report and literature review. Medicine (Baltimore). 2018;97(41):e12701. doi:10.1097/MD.000000000001270130313065
   PubMed Web of Science ®Google Scholar
• Albakr A, Alhothali W, Samghabadi P, et al. Central nervous system lymphoma in a patient with chronic lymphocytic leukemia: a case report and literature review. Cureus. 2018;10(11):e3660.30755837
   PubMed Web of Science ®Google Scholar
• Mihaljevic B, Smiljanic M, Antic D, et al. Chronic lymphocytic leukemia involvement of central nervous system: clinical diversity, diagnostic algorithm and therapeutic challenges. Ann Indian Acad Neurol. 2018;21(1):85–87.29720808
   PubMed Web of Science ®Google Scholar
• Tam CS, Kimber T, Seymour JF. Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia. Br J Haematol. 2017;176(5):829–831. doi:10.1111/bjh.1400026915463
   PubMed Web of Science ®Google Scholar
• Rojas-Hernandez CM, Nemunaitis J, Marjon KD, et al. Chronic lymphocytic leukemia with clinical debut as neurological involvement: a rare phenomenon and the need for better predictive markers. BMC Hematol. 2017;17:3. doi:10.1186/s12878-017-0073-028174663
   PubMedGoogle Scholar
• Khan K, Malik AI, Almarzouqi SJ, et al. Optic neuropathy due to chronic lymphocytic leukemia proven with optic nerve sheath biopsy. J Neuroophthalmol. 2016;36(1):61–66. doi:10.1097/WNO.000000000000030026436987
   PubMed Web of Science ®Google Scholar
• Wanquet A, Birsen R, Lemal R, et al. Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia. Blood. 2016;127(19):2356–2358. doi:10.1182/blood-2016-02-69719326994148
   PubMed Web of Science ®Google Scholar
• de Souza SL, Santiago F. Ribeiro-Carvalho, MeM, et al. Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature. BMC Res Notes. 2014;7::645.25218117
   PubMedGoogle Scholar
• Rossi C, Brisou G, Baseggio L, et al. Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management. Leuk Lymphoma. 2014;55(8):1939–1941. doi:10.3109/10428194.2013.85815224237449
   PubMed Web of Science ®Google Scholar
• Aziz M, Chaurasia JK, Khan R, et al. Primary low-grade diffuse small lymphocytic lymphoma of the central nervous system. BMJ Case Rep. 2014;2014.
   Google Scholar
• Benjamini O, Jain P, Schlette E, et al. Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease? Clin Lymphoma Myeloma Leuk. 2013;13(3):338–341. doi:10.1016/j.clml.2012.12.00723332395
   PubMed Web of Science ®Google Scholar
• Jain P, Benjamini O, Pei L, et al. Central nervous system Richter’s transformation and parvovirus B19 infection. Leuk Lymphoma. 2013;54(9):2070–2072. doi:10.3109/10428194.2013.76556523320889
   PubMed Web of Science ®Google Scholar
• Ishida F, Nakazawa H, Takezawa Y, et al. Richter transformation in the brain from chronic lymphocytic leukemia. J Clin Exp Hematop. 2013;53(2):157–160. doi:10.3960/jslrt.53.15723995113
   PubMedGoogle Scholar
• Gonsalves WI, Zent CS, Pulido JS, et al. Visual loss in early-stage chronic lymphocytic leukemia. J Clin Oncol. 2013;31(17):e280–282. doi:10.1200/JCO.2012.46.743123650405
   PubMed Web of Science ®Google Scholar
• Stuplich M, Mayer K, Kim Y, et al. Richter syndrome and brain involvement: low-grade lymphoma relapsing as cerebral high-grade lymphoma. Acta Haematol. 2012;127(2):93–95. doi:10.1159/00033406822156510
   PubMed Web of Science ®Google Scholar
• Imitola J, Pitt K, Peoples JL, et al. Multifocal CNS infiltration of chronic lymphocytic leukemia in the form of small-cell solid metastatic lesions. J Neurooncol. 2012;109(1):213–215. doi:10.1007/s11060-012-0869-522573347
   PubMed Web of Science ®Google Scholar
• Cohen JB, Cavaliere R, Byrd JC, et al. Hearing loss due to infiltration of the tympanic membrane by chronic lymphocytic leukemia. Case Rep Hematol. 2012;2012:589718.23198191
   PubMedGoogle Scholar
• Ackermann KA, Z’Graggen WJ, El-Koussy M, et al. Blindness in a patient with chronic lymphocytic leukemia. Am J Hematol. 2011;86(9):783–784. doi:10.1002/ajh.2204221630303
   PubMed Web of Science ®Google Scholar
• Graves TD, Collins GP, Parry A. Richter’s syndrome of the brain and the spinal cord. J Neurol Neurosurg Psychiatry. 2011;82(8):943–944. doi:10.1136/jnnp.2010.20975920587487
   PubMed Web of Science ®Google Scholar
• Kakimoto T, Nakazato T, Hayashi R, et al. Bilateral occipital lobe invasion in chronic lymphocytic leukemia. J Clin Oncol. 2010;28(3):e30–32. doi:10.1200/JCO.2009.23.843619884540
   PubMed Web of Science ®Google Scholar
• Russwurm G, Heinsch M, Radkowski R, et al. Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy. Blood. 2010;116(14):2617–2618. doi:10.1182/blood-2010-04-27978620930084
   PubMed Web of Science ®Google Scholar
• Calvo-Villas JM, Fernández JA, de la Fuente I, et al. Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter’s syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases. Br J Haematol. 2010;150(5):618–620. doi:10.1111/j.1365-2141.2010.08238.x20487439
   PubMed Web of Science ®Google Scholar